400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / ROS / Imeglimin
CAS No.: 775351-65-0
Synonyms: EMD 387008
Imeglimin is the first in a tetrahydrotriazine-containing class of oral antidiabetic agents, the glimins. It has been shown to act on the liver, muscle and pancreatic β-cells to uniquely target the key defects of type 2 diabetes.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01951235 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Latvia ... more >> Pauls Stradins Clinical University Hospital Riga, Latvia Collapse << |
NCT03646331 | Bioequivalence | Phase 1 | Not yet recruiting | October 2, 2018 | United Kingdom ... more >> Hammersmith Medicines Research (HMR) London, United Kingdom Collapse << |
NCT03618316 | Healthy | Phase 1 | Completed | - | United Kingdom ... more >> Hammersmith Medicines Research (HMR) London, United Kingdom Collapse << |
实验方案
技术信息
CAS号 | 775351-65-0 | 储存条件 |
|
|
分子式 | C6H13N5 | 运输 | 蓝冰 | |
分子量 | 155.20 | 别名 | EMD 387008 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01951235 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Latvia ... more >> Pauls Stradins Clinical University Hospital Riga, Latvia Collapse << |
NCT03646331 | Bioequivalence | Phase 1 | Not yet recruiting | October 2, 2018 | United Kingdom ... more >> Hammersmith Medicines Research (HMR) London, United Kingdom Collapse << |
NCT03618316 | Healthy | Phase 1 | Completed | - | United Kingdom ... more >> Hammersmith Medicines Research (HMR) London, United Kingdom Collapse << |
NCT02373150 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United Kingdom ... more >> Hammersmith Medicines Research (HMR) London, United Kingdom Collapse << |
NCT02924337 | Qt Interval, Variation in | Phase 1 | Completed | - | United Kingdom ... more >> Hammersmith Medicines Research (HMR) London, United Kingdom Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网